Sale by William E. Rote (Chief Research Officer)
9,100 shares · @ $39.09 · $355,719
Travere Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $47.18
+11% in 7d after detection
Post-detection moves
1h
—
1d
+0.8%
3d
-1.0%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS